KMDA · Kamada Ltd · Insider Trading

Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

Represents a "net exercise" of outstanding stock options. The reporting person received 1,783 ordinary shares on net exercise of option to purchase 6,500 ordinary shares. The Company withheld 4,717 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Represents a "net exercise" of outstanding stock options. The reporting person received 3,459 ordinary shares on net exercise of option to purchase 10,000 ordinary shares. The Company withheld 6,541 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.35, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

Represents a "net exercise" of outstanding stock options. The reporting person received 1,499 ordinary shares on net exercise of option to purchase 5,464 ordinary shares. The Company withheld 3,965 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.35, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026.

Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 9, 2026.

The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 8, 2026.

The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 7, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.53. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026.

The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.

Held by trustee under the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026.

The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.

Held by trustee under the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.53. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

This option was previously reported as covering 3,036 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

This option was previously reported as covering 3,036 ordinary shares at an exercise price of $6.11. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026.

Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

Represents a "net exercise" of outstanding stock options. The reporting person received 6,406 ordinary shares on net exercise of option to purchase 22,500 ordinary shares. The Company withheld 16,094 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.26, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

Represents a "net exercise" of outstanding stock options. The reporting person received 865 ordinary shares on net exercise of option to purchase 3,036 ordinary shares. The Company withheld 2,171 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.37, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

Represents a "net exercise" of outstanding stock options. The reporting person received 2,760 ordinary shares on net exercise of option to purchase 26,500 ordinary shares. The Company withheld 23,740 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 2, 2026 of $8.30, pursuant to the terms of the Company's 2011 Share Award Plan.

All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 2, 2026.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 400,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 16,000 ordinary shares at an exercise price of $6.27. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 7,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026.

This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.42. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 40,000 ordinary shares at an exercise price of $5.29. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.58. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026.

This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.42. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 29, 2026.

This option was previously reported as covering 30,000 ordinary shares at an exercise price of $5.39. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 15,000 ordinary shares at an exercise price of $9.57. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

Held by trustee under the Company's 2011 Share Award Plan.